TG Therapeutics reported $30.92M in Pre-Tax Profit for its fiscal quarter ending in June of 2025.


Pre Tax Profit Change Date
AbbVie USD 1.66B 3.15B Mar/2025
Alaunos Therapeutics USD -7843000 633K Dec/2023
Amgen USD 1.57B 405M Jun/2025
Ardelyx USD -19080000 23.76M Jun/2025
Arrowhead Research USD -179089000 548.7M Jun/2025
Bayer EUR -426000000 2.26B Jun/2025
Biogen USD 744M 432.8M Jun/2025
Corcept Therapeutics USD 31.69M 22.07M Jun/2025
Dynavax Technologies USD 21.22M 119.09M Jun/2025
Gilead Sciences USD 2.43B 780M Jun/2025
J&J USD 13.63B 8.21B Mar/2025
Novartis USD 4.53B 124M Jun/2025
PTC Therapeutics USD -71052000 1B Jun/2025
Regeneron Pharmaceuticals USD 1.52B 613.7M Jun/2025
Roche Holding CHF 1.78B 2.33B Dec/2024
TG Therapeutics USD 30.92M 25.45M Jun/2025
Vertex Pharmaceuticals USD 1.28B 552.6M Jun/2025